XTLB

NASDAQ · Equity

XTL Biopharmaceuticals Ltd ADR

US Healthcare Biotechnology

Latest week
29 May 2026
Close
2.440000
Fair value
5.597546
Expectation
Negative 43.81%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
2.44
12-Week Change
1.67%
Trend Signal
Inactive
Expectation
Negative 43.81%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-50.35
Market Dynamics
-0.20

Over the latest 12 completed weeks ending 2026-05-29, XTLB rose 1.67%, moving from 2.40 to 2.44. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -50.35 and has softened across the 12-week window. Market Dynamics is -0.20 on the latest week. Expectation is negative at 43.81%.